Europe Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

The Europe Sclerotherapy Market is expected to witness market growth of 7.5% CAGR during the forecast period (2020-2026).

Sclerotherapy is a medical procedure that is used to treat blood vessel or vascular deformities and also any malformations of the lymphatic system. In this procedure, medicine is introduced into the vessels, which results in their shrinking. It is used to treat vascular or lymphatic malformations in children and young adults. In adults, sclerotherapy is also used to treat spider veins, haemorrhoids, and smaller varicose veins.

This condition is beneficial and can be used to treatment by a dermatologist where an irritating medication is introduced into the vein to causes inflammation, fibrosis, endothelial damage, occlusion, and eventually overall absorption of the smaller vessels. In developed countries, about 30.0% of women and 10.0% of men consult the doctor for venous insufficiency signs and symptoms. Various factors like excess weight, heredity, and some professions that require prolonged period of sitting that may increase the risk of chronic venous disease of the legs. Long term thrombosis and varicose veins results in skin pigmentation, skin lesions, dermatitis, eczema, chronic edema, and ulcer.

The attention of both doctors and patients has been shifted towards less-invasive treatment procedures, availability of advanced treatment devices for varicose vein, as well as huge burden of varicose vein cases are the main driving factors in the growth of the market. Other factors include improvement in patient reliability and compliance, increasing healthcare expenditure, and swift growth in aging population.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent

• Detergents
• Osmotic Agents
• Chemical Irritants

By Type

• Liquid Sclerotherapy
• Ultrasound Sclerotherapy
• Foam Sclerotherapy

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Companies Profiled

• Boston Scientific Corporation
• Perrigo Company PLC (Omega Pharmaceuticals)
• Cook Medical, Inc. (Cook Group)
• Chemische Fabrik Kreussler & Co. GmbH
• LGM Pharma, LLC
• Troikaa Pharmaceuticals Limited
• Tianyu Chang’an Group
• Endo-Flex GmbH (Meditek Systems)
• Merz Pharma GmbH & Co. KGaA
• MTW-Endoskopie W. Haag KG

Unique Offerings from the Publisher

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free